Ronit Sarid is an associate professor at the Faculty of Life Sciences of Bar Ilan University. She received her PhD in Virology from the Tel Aviv University. Subsequently, during her post-doctoral training, at Tel Aviv University and then at Columbia University (New York), she has specialized on herpesvirus biology, in particular on the Kaposi's sarcoma-associated herpesviruses (KSHV). KSHV is one few viruses proven to be associated with cancer in humans and she has been engaged on the study of this virus almost from its discovery. Of note, the study of KSHV is important from clinical and public health standpoints, but also provides a source of basic information on how viruses might induce cellular proliferation and transformation. Currently, her research focuses on cellular and viral pathways involved in KSHV infection and pathogenesis. In addition, she is involved in developing composite nanoparticles for the inhibition of herpesvirus infection.